Abeona Therapeutics develops cell and gene therapies, led by ZEVASKYN, a treatment for skin wounds caused by a rare inherited skin disease. It last closed at $2.42 on Nov 20, down 1.22% on the day. The next earnings report for ABEO is expected around Tue, Mar 16, 2027. For the quarter ended Sep 2026, ABEO reported EPS of -$0.08 on revenue of $13.5M. Over its last 8 reports the stock moved an average of 12.5% the session after earnings. Over the last 12 months ABEO insiders bought $34K of stock on the open market and sold $3.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is ABEO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ABEO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ABEOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ABEO · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 40% below its 20 day and 81% below its 50 day average. It is 120% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $2.36, and the nearest resistance the Pivot at $2.46.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 12.2%/day
Key levels
$7.6552 week high+216.1%
$5.39100 day average+122.7%
$5.33200 day average+120.2%
$4.67Swing high (Oct 21)+93.0%
$4.3850 day average+81.0%
$3.3920 day average+40.1%
$2.53Pivot R1+4.5%
$2.46Pivot+1.7%
$2.42Last close
$2.36Pivot S1−2.5%
$2.0952 week low−13.6%
$2.09Swing low (Nov 13)−13.6%
Indicators
RSI (14)
26.69
Oversold below 30
Oversold
MACD
-0.62
Below its signal line
Bearish
Stochastic
18.5
Near the bottom of its range
Oversold
ADX (14)
46.3
Strong downtrend
Williams %R
-85.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-69.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−42.0%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 12.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 28.1%/day
Key levels
$7.6552 week high+216.1%
$5.39100 day average+122.7%
$5.33200 day average+120.2%
$4.67Swing high (Oct 21)+93.0%
$4.3850 day average+81.0%
$3.3920 day average+40.1%
$2.53Pivot R1+4.5%
$2.46Pivot+1.7%
$2.42Last close
$2.36Pivot S1−2.5%
$2.0952 week low−13.6%
$2.09Swing low (Nov 13)−13.6%
Indicators
RSI (14)
23.94
Oversold below 30
Oversold
MACD
-0.66
Below its signal line
Bearish
Stochastic
6.9
Near the bottom of its range
Oversold
ADX (14)
26.6
Trending down
Williams %R
-92.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-190.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−55.3%
Change over 10 sessions
Bearish
ATR (14)
$0.68
Typical daily range, 28.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ABEO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABEO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ABEO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ABEOHow many large options trades hit ABEO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ABEO in the last 90 days.
From SEC Form 4 filings by ABEO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABEO is in one of them and how their past ABEO trades turned out.
Abeona Therapeutics is a biopharmaceutical company based in Cleveland, Ohio, that develops cell and gene therapies for rare genetic diseases. Its main product, ZEVASKYN, treats skin wounds in patients with recessive dystrophic epidermolysis bullosa, a rare inherited skin disease. The treatment uses a patient's own skin cells, which are modified and applied surgically at specialized treatment centers. Its pipeline also includes gene therapies for eye diseases.